Latest News
Repligen Corporation
- Repligen Corporation Estimates – XETR:RGN
- Repligen: A Buy As Its Growth Engine Gears Up (NASDAQ:RGEN)
- Repligen Drops 5.0% Amid Sector-Wide Selling
- Repligen Completes Acquisition of BioLife Solutions
- Repligen Completes BioLife Solutions Acquisition, Expanding Cell Therapy Platform
- Repligen completes acquisition of BioLife Solutions
- Repligen CEO Olivier Loeillot sells $1.03m of company stock
- Form 4 Repligen Corporation For: 6 October By Investing.com
- BioLife Solutions Shareholders Approve Repligen Merger Agreement
- Form 144 REPLIGEN CORP For: 5 October By Investing.com
- Repligen CEO Olivier Loeillot sells $976,680 in company stock
- Form 4 Repligen Corporation For: 26 September By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →